Home
Conditions
Immune System Diseases

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

81 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

Implementation of Support in the Care of Adults Living With Type 1 Diabetes

NCT06069583

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +7 more
Locations: Institut de recherches cliniques de Montréal Montreal, Quebec, Canada

Centre hospitalier de l'université de Montreal Montreal, Quebec, Canada

Centre hospitalier de Quebec, Université Laval Québec, Quebec, Canada

Centre de médecine métabolique de Lanaudière Terrebonne, Quebec, Canada

View Trial Details

Recruiting

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

NCT06271252

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Northside Hospital Atlanta, Georgia, United States

View Trial Details

Not yet recruiting

Clonal Hematopoiesis of Immunological Significance

NCT05969821

Conditions: Autoimmune Diseases, Autoinflammatory Diseases, Blood Protein Disorders, +27 more
Locations: AP-HP, Service de médecine interne, Hôpital Saint Antoine Paris, France

View Trial Details

Not yet recruiting

Digital Diagnostics and Intervention Services for Parkinson's Disease

NCT06534177

Conditions: Arthritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +31 more
Locations: Not specified

View Trial Details

Active, not recruiting

Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma

NCT03672318

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States

View Trial Details

Active, not recruiting

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

NCT03922724

Conditions: Autoimmune Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

National Marrow Donor Program Minneapolis, Minnesota, United States

View Trial Details

Active, not recruiting

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

NCT03696784

Conditions: Chemically-Induced Disorders, Cytokine Release Syndrome, Hemic and Lymphatic Diseases, +17 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Active, not recruiting

Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL

NCT02690545

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Active, not recruiting

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

NCT03602157

Conditions: Cutaneous Anaplastic Large Cell Lymphoma, Cutaneous Lymphoma, Cutaneous T Cell Lymphoma, +15 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Active, not recruiting

Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL

NCT03016377

Conditions: Acute Lymphoblastic Leukemia, Cytokine Release Syndrome, Hematologic Diseases, +15 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Immune System Diseases

Immune System Diseases trial results

Related conditions